Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 75
Page ix
... combined chemotherapy plays in treating this disease are discussed in depth. The chapters in Part Three address the special issues that face lung cancer patients: fatigue, end of life, nutrition, dyspnea, and radon exposure. In Part ...
... combined chemotherapy plays in treating this disease are discussed in depth. The chapters in Part Three address the special issues that face lung cancer patients: fatigue, end of life, nutrition, dyspnea, and radon exposure. In Part ...
Page 7
... combined oat cell (SCLC combined with squamous cell or adenocarcinoma) (Hirsch et al., 1988). In 1999, the WHO and the International Association for the Study of Lung Cancer (IASLC) eliminated the intermediate cell carcinoma and added a ...
... combined oat cell (SCLC combined with squamous cell or adenocarcinoma) (Hirsch et al., 1988). In 1999, the WHO and the International Association for the Study of Lung Cancer (IASLC) eliminated the intermediate cell carcinoma and added a ...
Page 12
... combinations of healthy elements, such as antioxidants (http://www.your diseaserisk.wustl.edu). The focus for healthcare providers should be placed on prevention and reduction to exposure. More public education is needed about the risks ...
... combinations of healthy elements, such as antioxidants (http://www.your diseaserisk.wustl.edu). The focus for healthcare providers should be placed on prevention and reduction to exposure. More public education is needed about the risks ...
Page 27
... combined modality therapy, and to assess risk of mortality from aggressive chemotherapy. Given that surgery plays a ... combination small cell carcinoma. The mixed small cell/large cell SCLC is distinguished by the presence of prominent ...
... combined modality therapy, and to assess risk of mortality from aggressive chemotherapy. Given that surgery plays a ... combination small cell carcinoma. The mixed small cell/large cell SCLC is distinguished by the presence of prominent ...
Page 33
You have reached your viewing limit for this book.
You have reached your viewing limit for this book.
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase postoperative potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss